MedPath

Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Completed
Conditions
Head and Neck Neoplasms
Registration Number
NCT00180180
Lead Sponsor
Technische Universität Dresden
Brief Summary

The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • histologically confirmed head-and-neck cancer not curable by surgery
  • Karnofsky > 70%
  • tumor volume and localisation allow curative radiotherapy
  • written consent
Exclusion Criteria
  • metastases
  • earlier radiation therapy of head and neck
  • pregnancy
  • secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri
  • psychiatric impairment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Nuclear Medicine

🇩🇪

Dresden, Germany

© Copyright 2025. All Rights Reserved by MedPath